Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12931-015-0253-z http://scihub22266oqcxt.onion/10.1186/s12931-015-0253-z C4570035!4570035 !26369337     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26369337 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Respir+Res 2015 ; 16 (1 ): 106 Nephropedia Template TP {{tp|p=26369337 |t=2015. Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways |pdf=|usr=}}{{26369337 }} gab.com Text Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways JO: Respir Res http://www.kidney.de/pget.php?&tw=1&pmid=26369337 #FOAvip BACKGROUND: It is widely recognized that deep inspiration (DI), either before methacholine (MCh) challenge (Bronchoprotection, BP) or after MCh challenge (Bronchodilation, BD) protects against this challenge in healthy individuals, but not in asthmatics. Sulforaphane, a dietary antioxidant and antiinflammatory phytochemical derived from broccoli, may affect the pulmonary bronchoconstrictor responses to MCh and the responses to DI in asthmatic patients. METHODS: Forty-five moderate asthmatics were administered sulforaphane (100 ?mol daily for 14 days), BP, BD, lung volumes by body-plethsmography, and airway morphology by computed tomography (CT) were measured pre- and post sulforaphane consumption. RESULTS: Sulforaphane ameliorated the bronchoconstrictor effects of MCh on FEV1 significantly (on average by 21 %; p?=?0.01) in 60 % of these asthmatics. Interestingly, in 20 % of the asthmatics, sulforaphane aggravated the bronchoconstrictor effects of MCh and in a similar number was without effect, documenting the great heterogeneity of the responsiveness of these individuals to sulforaphane. Moreover, in individuals in whom the FEV1 response to MCh challenge decreased after sulforaphane administration, i.e., sulforaphane was protective, the activities of Nrf2-regulated antioxidant and anti-inflammatory genes decreased. In contrast, individuals in whom sulforaphane treatment enhanced the FEV1 response to MCh, had increased expression of the activities of these genes. High resolution CT scans disclosed that in asthmatics sulforaphane treatment resulted in a significant reduction in specific airway resistance and also increased small airway luminal area and airway trapping modestly but significantly. CONCLUSION: These findings suggest the potential value of blocking the bronchoconstrictor hyperresponsiveness in some types of asthmatics by phytochemicals such as sulforaphane. Twit Text FOAVip Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways ????Respir Res http://www.kidney.de/pget.php?&tw=1&pmid=26369337 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26369337 #FOAvip English Wikipedia <ref>{{Cite pmid|26369337 }}</ref> Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways #MMPMID26369337 Brown RH ; Reynolds C ; Brooker A ; Talalay P ; Fahey JW Respir Res 2015[Sep]; 16 (1 ): 106 PMID26369337 show ga BACKGROUND: It is widely recognized that deep inspiration (DI), either before methacholine (MCh) challenge (Bronchoprotection, BP) or after MCh challenge (Bronchodilation, BD) protects against this challenge in healthy individuals, but not in asthmatics. Sulforaphane, a dietary antioxidant and antiinflammatory phytochemical derived from broccoli, may affect the pulmonary bronchoconstrictor responses to MCh and the responses to DI in asthmatic patients. METHODS: Forty-five moderate asthmatics were administered sulforaphane (100 ?mol daily for 14 days), BP, BD, lung volumes by body-plethsmography, and airway morphology by computed tomography (CT) were measured pre- and post sulforaphane consumption. RESULTS: Sulforaphane ameliorated the bronchoconstrictor effects of MCh on FEV1 significantly (on average by 21 %; p?=?0.01) in 60 % of these asthmatics. Interestingly, in 20 % of the asthmatics, sulforaphane aggravated the bronchoconstrictor effects of MCh and in a similar number was without effect, documenting the great heterogeneity of the responsiveness of these individuals to sulforaphane. Moreover, in individuals in whom the FEV1 response to MCh challenge decreased after sulforaphane administration, i.e., sulforaphane was protective, the activities of Nrf2-regulated antioxidant and anti-inflammatory genes decreased. In contrast, individuals in whom sulforaphane treatment enhanced the FEV1 response to MCh, had increased expression of the activities of these genes. High resolution CT scans disclosed that in asthmatics sulforaphane treatment resulted in a significant reduction in specific airway resistance and also increased small airway luminal area and airway trapping modestly but significantly. CONCLUSION: These findings suggest the potential value of blocking the bronchoconstrictor hyperresponsiveness in some types of asthmatics by phytochemicals such as sulforaphane. |Adult [MESH] |Airway Resistance/drug effects [MESH] |Antioxidants/*administration & dosage/adverse effects [MESH] |Asthma/diagnosis/*drug therapy/genetics/metabolism/physiopathology [MESH] |Bronchial Hyperreactivity/diagnosis/*drug therapy/genetics/metabolism/physiopathology [MESH] |Bronchial Provocation Tests/methods [MESH] |Bronchoconstriction/*drug effects [MESH] |Bronchoconstrictor Agents/administration & dosage [MESH] |Female [MESH] |Forced Expiratory Volume/drug effects [MESH] |Gene Expression Regulation [MESH] |Humans [MESH] |Isothiocyanates/*administration & dosage/adverse effects [MESH] |Lung Volume Measurements/methods [MESH] |Lung/diagnostic imaging/*drug effects/metabolism/physiopathology [MESH] |Male [MESH] |Methacholine Chloride/administration & dosage [MESH] |Middle Aged [MESH] |NF-E2-Related Factor 2/genetics/*metabolism [MESH] |Predictive Value of Tests [MESH] |Sulfoxides [MESH] |Time Factors [MESH] |Tomography, Spiral Computed [MESH] |Treatment Outcome [MESH]Sulforaphane improves the bronchoprotective response in asthmatics thr(epmc).pdf DeepDyve Pubget Overpricing